• Novamind Ventures Inc. signed a letter of intent with Hinterland Metals Inc. to list on the Canadian Securities Exchange (CSE). The company is also currently undertaking a non-brokered private placement at a price of $0.10 per Novamind share for gross proceeds of $3,000,000 to be completed prior to the closing of the transaction.
  • Cybin Corp. announced a reverse takeover transaction with Clarmin Explorations Inc. (TSX.V: CX). Cybin also plans to complete a brokered private placement of subscription receipts of Cybin to raise a minimum of $14 million (US$10 million) and a maximum of $21 million (US$15 million).
  • Field Trip Psychedelics Inc. announced a letter of intent with Newton Energy Corporation (TSX.V: NTN.H). In addition, the company plans to complete a brokered private placement of common shares at a price of $2.00 per common share for gross proceeds of between $14 million and $15 million.
  • Silo Wellness Inc. announced a proposed reverse takeover with Yukoterre Resources Inc. (CSE: YT). In connection with the transaction, the company will complete a private placement for gross proceeds of approximately $2.5 million.
  • Entheon Biomedical Corp. announced a definitive amalgamation agreement with MPV Exploration Inc. to list on the CSE. In conjunction, it will complete a non-brokered private placement of subscription receipts to raise C$2 million in working capital.
  • Mindset Pharma Inc. announced a binding letter of intent for a reverse merger with North Sur Resources Inc. to list on the CSE. In addition, the company announced an initial private placement of up to $1 million through the issuance of 6,666,666 shares at $0.15 per share.
  • Havn Life Sciences announced the launch and filing of its preliminary prospectus.